Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82.

Senn, H J; Maibach, R; Castiglione, M; Jungi, W F; Cavalli, F; Leyvraz, S; Obrecht, J P; Schildknecht, O; Siegenthaler, P

Senn, H J; Maibach, R; Castiglione, M; Jungi, W F; Cavalli, F; Leyvraz, S; Obrecht, J P; Schildknecht, O; Siegenthaler, P.

Affiliation

Senn HJ; Department of Medicine C, Kantonsspital, St Gallen, Switzerland. mccs@msl.kssg.ch

J Clin Oncol ; 15(7): 2502-9, 1997 Jul.

Article in En | MEDLINE | ID: mdl-9215818

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Breast Neoplasms/metabolism; Breast Neoplasms/pathology; Breast Neoplasms/surgery; Chemotherapy, Adjuvant; Chlorambucil/administration & dosage; Cyclophosphamide/administration & dosage; Drug Administration Schedule; Female; Fluorouracil/administration & dosage; Humans; Lymphatic Metastasis; Menopause; Methotrexate/administration & dosage; Middle Aged; Switzerland; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: J Clin Oncol Year: 1997 Type: Article Affiliation country: Switzerland

Search on Google

XML

PubMed Links